CHERRY HILL, N.J., Aug. 5 /PRNewswire/ -- TriMix Laboratories LLC today announced it has entered into an agreement with American Pharmacy Solutions as the exclusive pharmacy for prescription fulfillment of TriMix gel(TM). TriMix gel(TM) has been prescribed by doctors as a first line and secondary treatment for erectile dysfunction (ED). American Pharmacy Solutions (APS) is a licensed compounding pharmacy which makes TriMix gel(TM) medicine for each individual patient in response to a prescription from a physician. For more information on TriMix gel(TM), visit http://www.trimixgel.com .
APS Owner and President Steve Berklow states, "Our 50 years of experience in the pharmacy industry leaves us uniquely qualified to enter into this relationship with TriMix Laboratories. We look forward to delivering top shelf quality service and medicine to our patients."
T.J. Harkins, President of TriMix Laboratories commented, "We are happy to have APS on board with us. They are a first class operation and they will undoubtedly make a positive reflection on us and become an important part of our patients' health care regimen with TriMix gel(TM) and the other quality products they provide."
TriMix gel(TM) is a gel-based treatment which has been prescribed for ED patients who have failed on Viagra(R), Levitra(R) and Cialis(R) type tablets or who could not tolerate the side effects. It uses an all-in-one ED gel(TM) Application System (pat. pend.) which stores, mixes and applies the medicine at time of use. One feature of this methodology of medicine delivery is that the medicine in this form does not have to be refrigerated and can be carried by the patient at room temperature. Additionally, TriMix gel(TM) uses FDA approved vasodilation components but does not have to be self injected with a needle because it is classified as a topical gel.
TriMix gel contains active ingredients which are classified
|SOURCE TriMix Laboratories LLC|
Copyright©2008 PR Newswire.
All rights reserved